{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:40:43Z","timestamp":1791272443714,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.vaccine.2010.03.028","type":"journal-article","created":{"date-parts":[[2010,3,27]],"date-time":"2010-03-27T08:22:46Z","timestamp":1269678166000},"page":"3977-3989","source":"Crossref","is-referenced-by-count":69,"title":["Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans"],"prefix":"10.1016","volume":"28","author":[{"given":"Tze Guan","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Mui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Witola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Montpetit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Muench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Sidney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajesh","family":"Maewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.03.028_bib1","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ijpara.2004.06.007","article-title":"Genetic diversity, clonality and sexuality in Toxoplasma gondii","volume":"34","author":"Ajzenberg","year":"2004","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-90-1-47","article-title":"Probable transmission of Toxoplasma gondii by organ transplantation","volume":"90","author":"Ryning","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2010.03.028_bib3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4049\/jimmunol.146.1.286","article-title":"Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine","volume":"146","author":"Gazzinelli","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.3128869","article-title":"Interferon-gamma: the major mediator of resistance against Toxoplasma gondii","volume":"240","author":"Suzuki","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2010.03.028_bib5","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.4049\/jimmunol.145.10.3438","article-title":"Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection","volume":"145","author":"Brown","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib6","first-page":"419","article-title":"Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis","volume":"85","author":"Brown","year":"1995","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2010.03.028_bib7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4049\/jimmunol.169.2.966","article-title":"In vitro correlates of Ld-restricted resistance to toxoplasmic encephalitis and their critical dependence on parasite strain","volume":"169","author":"Johnson","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib8","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/501360","article-title":"Outcome of treatment for congenital toxoplasmosis, 1981\u20132004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study","volume":"42","author":"McLeod","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2010.03.028_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1590\/S0074-02762009000200029","article-title":"Why prevent, diagnose and treat congenital toxoplasmosis?","volume":"104","author":"McLeod","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2010.03.028_bib10","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.4049\/jimmunol.140.5.1632","article-title":"Subcutaneous and intestinal vaccination with tachyzoites of Toxoplasma gondii and acquisition of immunity to peroral and congenital toxoplasma challenge","volume":"140","author":"McLeod","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib11","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.vaccine.2007.02.057","article-title":"Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice","volume":"25","author":"Golkar","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.028_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s004360000296","article-title":"Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii","volume":"87","author":"Leyva","year":"2001","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2010.03.028_bib13","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.micinf.2005.11.013","article-title":"Immunization with MIC1 and MIC4 induces protective immunity against Toxoplasmagondii","volume":"8","author":"Lourenco","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2010.03.028_bib14","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1128\/IAI.67.12.6358-6363.1999","article-title":"Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene","volume":"67","author":"Nielsen","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.03.028_bib15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ni.1629","article-title":"Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum","volume":"9","author":"Blanchard","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib16","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1084\/jem.176.6.1681","article-title":"Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex","volume":"176","author":"Corr","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.03.028_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2172-9-1","article-title":"HLA class I supertypes: a revised and updated classification","volume":"9","author":"Sidney","year":"2008","journal-title":"BMC Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib18","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s00251-002-0530-0","article-title":"Class I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution","volume":"54","author":"Sette","year":"2003","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2010.03.028_bib19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/hum.2006.17.415","article-title":"Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of Toxoplasmagondii induces immune response and protection against infection in mice","volume":"17","author":"Caetano","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2010.03.028_bib20","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/593019","article-title":"Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes","volume":"198","author":"Frickel","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.03.028_bib21","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.4049\/jimmunol.162.5.3088","article-title":"Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans","volume":"162","author":"Livingston","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib22","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1128\/JVI.76.9.4212-4221.2002","article-title":"Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus","volume":"76","author":"Deliyannis","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1365-2567.2002.01396.x","article-title":"Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses","volume":"106","author":"BenMohamed","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2010.03.028_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1473-3099(02)00318-3","article-title":"Lipopeptide vaccines\u2014yesterday, today, and tomorrow","volume":"2","author":"BenMohamed","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2010.03.028_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","article-title":"New horizons in adjuvants for vaccine development","volume":"30","author":"Reed","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib26","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.4049\/jimmunol.169.9.4905","article-title":"Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines","volume":"169","author":"Zeng","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib27","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.4049\/jimmunol.162.7.3915","article-title":"Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes","volume":"162","author":"Ishioka","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib28","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0966-842X(02)02426-5","article-title":"Taking toll: lipid A mimetics as adjuvants and immunomodulators","volume":"10","author":"Persing","year":"2002","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s002510050594","article-title":"Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism","volume":"50","author":"Sette","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2010.03.028_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.immuni.2007.04.003","article-title":"The final touches make perfect the peptide-MHC class I repertoire","volume":"26","author":"Hammer","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2010.03.028_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0198-8859(02)00786-3","article-title":"Derivation of HLA-B*0702 transgenic mice: functional CTL repertoire and recognition of human B*0702-restricted CTL epitopes","volume":"64","author":"Alexander","year":"2003","journal-title":"Hum Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib32","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1086\/374647","article-title":"Serotyping of Toxoplasmagondii infections in humans using synthetic peptides","volume":"187","author":"Kong","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.03.028_bib33","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0020-7519(99)00152-6","article-title":"HLA-class II genes modify outcome of Toxoplasma gondii infection","volume":"29","author":"Mack","year":"1999","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib34","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.1128\/JVI.00896-06","article-title":"Identification of protective Lassa virus epitopes that are restricted by HLA-A2","volume":"80","author":"Botten","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00251-005-0781-7","article-title":"The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage","volume":"57","author":"Nielsen","year":"2005","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2010.03.028_bib36","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1128\/IAI.01862-06","article-title":"Bradyzoite-specific surface antigen SRS9 plays a role in maintaining Toxoplasma gondii persistence in the brain and in host control of parasite replication in the intestine","volume":"75","author":"Kim","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.03.028_bib37","doi-asserted-by":"crossref","first-page":"e2285","DOI":"10.1371\/journal.pone.0002285","article-title":"Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis","volume":"3","author":"Jamieson","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2010.03.028_bib38","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1128\/IAI.01494-07","article-title":"A cluster of four surface antigen genes specifically expressed in bradyzoites, SAG2CDXY, plays an important role in Toxoplasma gondii persistence","volume":"76","author":"Saeij","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.03.028_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-7580-4-2","article-title":"Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries","volume":"4","author":"Sidney","year":"2008","journal-title":"Immunome Res"},{"key":"10.1016\/j.vaccine.2010.03.028_bib40","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0198-8859(01)00319-6","article-title":"Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules","volume":"62","author":"Sidney","year":"2001","journal-title":"Hum Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1803s31","article-title":"Measurement of MHC\/peptide interactions by gel filtration","author":"Sidney","year":"2001","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib42","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib43","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1006\/jmbi.1997.0937","article-title":"Two complementary methods for predicting peptides binding major histocompatibility complex molecules","volume":"267","author":"Gulukota","year":"1997","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib44","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1002\/eji.200636234","article-title":"The structure of the human allo-ligand HLA-B*3501 in complex with a cytochrome p450 peptide: steric hindrance influences TCR allo-recognition","volume":"36","author":"Hourigan","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1074-7613(00)80560-9","article-title":"Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes","volume":"8","author":"Speir","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2010.03.028_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0923-2494(05)80096-3","article-title":"Excreted\/secreted antigens of Toxoplasma gondii\u2014their origin and role in the host-parasite interaction","volume":"144","author":"Cesbron-Delauw","year":"1993","journal-title":"Res Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib47","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/eji.1830211102","article-title":"Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells","volume":"21","author":"Schild","year":"1991","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib48","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0264-410X(98)00250-3","article-title":"Lipopeptide particles as the immunologically active component of CTL inducing vaccines","volume":"17","author":"Tsunoda","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.028_bib49","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ni1208","article-title":"Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum","volume":"6","author":"Saveanu","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ni1286","article-title":"The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules","volume":"7","author":"Hammer","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2010.03.028_bib51","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1086\/427660","article-title":"A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts","volume":"191","author":"Beghetto","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.03.028_bib52","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2307\/3284282","article-title":"Oocyst-induced murine toxoplasmosis: life cycle, pathogenicity, and stage conversion in mice fed Toxoplasma gondii oocysts","volume":"83","author":"Dubey","year":"1997","journal-title":"J Parasitol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10003750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10003750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T08:36:38Z","timestamp":1685522198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10003750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":52,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0264410X10003750"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.03.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}